INTERFERON-ALPHA-2 (IFN) PLUS HYDROXYUREA FOR TREATMENT OF JUVENILE CHRONIC MYELOGENOUS LEUKEMIA

被引：4
|
作者：
SUTTORP, M
RISTER, M
SCHMITZ, N
机构：
[1] CHRISTIAN ALBRECHTS UNIV KIEL,DEPT PEDIAT,W-2300 KIEL 1,GERMANY
[2] CHRISTIAN ALBRECHTS UNIV KIEL,DEPT INTERNAL MED 2,BONE MARROW TRANSPLANT UNIT,W-2300 KIEL 1,GERMANY
[3] KRANKENHAUS KEMPERHOF,DEPT PEDIAT,W-5400 KOBLENZ,GERMANY
[4] CHRISTIAN ALBRECHTS UNIV KIEL,CHILDRENS HOSP,CHWANENWEG 20,D-24105 KIEL,GERMANY
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1994年 / 22卷 / 05期
关键词：
D O I：
10.1002/mpo.2950220513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：358 / 359
页数：2
相关论文
共 50 条
  • [21] ALPHA-INTERFERON AND CHRONIC MYELOGENOUS LEUKEMIA
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (16): : 2137 - 2140
  • [22] INTERFERON IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA
    HUBER, C
    BLUT, 1988, 57 (04): : 221 - 221
  • [23] TREATMENT OF HAIRY-CELL LEUKEMIA WITH RECOMBINANT INTERFERON-ALPHA-2
    BERNEMAN, ZN
    GASTL, G
    GANGJI, D
    VANCAMP, B
    JOCHMANS, K
    AULITZKY, W
    FLAMENT, J
    PEETERMANS, ME
    HUBER, C
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (08): : 987 - 990
  • [24] INTERFERON IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA
    SCHMIDT, CG
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 112 (49) : 1919 - 1919
  • [25] HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA
    KENNEDY, BJ
    ANNALS OF INTERNAL MEDICINE, 1969, 70 (05) : 1084 - +
  • [26] EFFECT OF RECOMBINANT INTERFERON-ALPHA-2 ON THE GROWTH OF HAEMATOPOETIC PROGENITOR CELLS IN CHRONIC MYELOGENOUS LEUKEMIA AND ITS RELATIONSHIP TO THE CLINICAL EFFICACY
    GEISSLER, D
    AULITZKY, W
    TILG, H
    VONLUTTICHAU, I
    KONWALINKA, G
    HUBER, C
    GASTL, G
    BLUT, 1987, 55 (04): : 386 - 386
  • [27] CONCURRENT ADMINISTRATION OF INTERFERON-ALPHA-2 (IFN) AND DOXORUBICIN (DOX)
    SPEYER, JL
    GREEN, MD
    WERNZ, JC
    DUNLEAVY, S
    BLUM, RH
    WIDMAN, T
    MUGGIA, FM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 182 - 182
  • [28] HYDROXYUREA VERSUS BUSULFAN IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA
    RUSHING, D
    GOLDMAN, A
    GIBBS, G
    HOWE, R
    KENNEDY, BJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (03): : 307 - 313
  • [29] Sustained molecular responses with interferon α2a maintenance therapy after imatinib plus IFN induction treatment for chronic phase chronic myelogenous leukemia
    Hochhaus, Andreas
    Neubauer, Andreas
    Mueller, Martin C.
    Napieralski, Simone
    Erben, Philipp
    Bostel, Tilmar
    Hehlmann, Ruediger
    Burchert, Andreas
    BLOOD, 2007, 110 (11) : 16A - 17A
  • [30] INTERFERON ALPHA-2A IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - RESULTS OF THE SPANISH GROUP
    FERNANDEZRANADA, JM
    LAVILLA, E
    ODRIOZOLA, J
    GARCIALARANA, J
    LOZANO, M
    PARODY, R
    GIRALDO, MP
    CARBONELL, F
    FERRO, MT
    STEEGMANN, JL
    LEUKEMIA & LYMPHOMA, 1993, 11 : 175 - 179
12345